… Existing patients can call 1-888-663-3488. Non-Hodgkin lymphoma survival continues to fall beyond five years after diagnosis. Many types of non-Hodgkin lymphoma respond favorably to treatment, but it’s still important for people who have achieved partial or total remission to be aware of the potential for a recurrence. Many types of non-Hodgkin lymphoma respond favorably to treatment, but it’s still important for people who have achieved partial or total remission to be aware of the potential for a recurrence. Learn More. New Patients and Healthcare Professionals can submit an online form by selecting the appropriate buttonbelow. Notice to Our Patients Regarding a Stolen Briefcase. Combination chemotherapy results in 10-year disease-free survival (DFS) and overall survival (OS) rates of 57% to 81% and 57% to 89%, respectively. REFERRING PHYSICIANS Providers and medical staff can refer patients by submitting our online referral form. Patient Appointment Center Hours: 7 a.m. to 7 p.m. Monday - Friday; 8 a.m. to noon Saturday, STORIES TO INSPIRE YOU ON YOUR JOURNEY THROUGH CANCER. For instance, as compared to standard chemotherapy, high-dose chemotherapy followed by stem cell transplantation may produce a better outcome for recurrent non-Hodgkin lymphoma. Because most recurrent lymphomas are diagnosed within the first two years of entering remission, a follow-up schedule typically includes frequent visits during this time period, with the frequency reduced gradually as more time passes. Moffit now offers Virtual Visits for patients. To check for signs of a potential non-Hodgkin lymphoma recurrence, physicians may perform: Survivors of non-Hodgkin lymphoma are also advised to remain aware of any potential symptoms, such as unexplained fever, night sweats or swelling of the lymph nodes in the neck or underarms, and to schedule an appointment with an oncologist if any unusual changes develop. 51.8% of males and 58.1% of females are predicted to survive their disease for ten years or more, as shown by age-standardised net survival for patients diagnosed with non-Hodgkin lymphoma during 2013-2017 in … For example, if the 5-year relative survival ratefor a specific stage of NHL is 70%, it means that people who have that cancer are, on average, about 70% as likely as people who don’t have that cancer to live for at least 5 years after being diagnosed. For more information on how we’re protecting our new and existing patients, visit our COVID-19 Info Hub. If you’re concerned about a potential non-Hodgkin lymphoma recurrence and would like to request an appointment at Moffitt Cancer Center, call 1-888-663-3488 or submit a new patient registration form online. A relative survival rate compares people with the same type and stage of non-Hodgkin lymphoma (NHL) to people in the overall population. Moffitt Cancer Center is committed to the health and safety of our patients and their families. Click here for a current list of insurances accepted at Moffitt. Patients whose initial remission … If you are eligible for a virtual appointment, our scheduling team will discuss this option further with you. At Moffitt Cancer Center, our goal is to provide each patient with the best possible outcome and quality of life, regardless of the type and stage of the cancer. An online resource for referring physicians and their staff. When non-Hodgkin lymphoma comes back after treatment is completed, it is called a recurrence. It greatly depends upon the response of the treatment and the cancer relapse.